Univest
Univest
  • Markets

Everest Organics Ltd. (EVERESTO) Share Price Rises 12.78% Today

  • October 5, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Everest Organics Share Price
Everest Organics Ltd. (EVERESTO) share price rose to Rs 247.9 today, up 12.78% from the previous close. Market cap was Rs 219.22 crore.

Everest Organics Share Price is trading higher today at Rs 247.9, after a 12.78% rise from the previous close of Rs 219.8. The company’s market capitalisation stands at Rs 219.22 crore, placing Everest Organics Share Price in the spotlight across Healthcare shares. Univest data confirms the move itself, though no company-specific trigger has been identified.

The latest Univest figures show an intraday move that began at Rs 259, matched the day’s high at Rs 259 and touched a low of Rs 221. That range keeps Everest Organics Share Price firmly in focus for traders tracking Everest Organics Share Price Today, Everest Organics Stock News and Everest Organics Share Price Update. The move is important because it is a clear share price gain without a verified news trigger, so the price action itself becomes the main story. Investors watching Everest Organics Share Price on NSE and BSE will also want to compare the move with the company’s valuation and the Healthcare sector backdrop.

Table of Contents

Toggle
  • Everest Organics Share Price Today: Price Action Analysis
  • Everest Organics Ltd. (EVERESTO) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Everest Organics
  • About Everest Organics
  • Frequently Asked Questions
    • Why is Everest Organics Share Price rising today?
    • What is Everest Organics Share Price today?
    • How much did Everest Organics Share Price rise today?
    • What does Everest Organics Share Price valuation show?
    • How does Everest Organics compare with Healthcare peers?
    • What is Everest Organics market capitalisation?
    • What are the key fundamentals for Everest Organics Share Price?
    • Should investors track Everest Organics Share Price on Univest?
  • Track Everest Organics Share Price on Univest

Everest Organics Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 247.9
Previous Close Rs 219.8
Today's Move Rs 28.1 (+12.78%)
Open Rs 259
High Rs 259
Low Rs 221
Market Capitalisation Rs 219.22 crore
Market Cap Category Micro Cap

Everest Organics Ltd. (EVERESTO) rose to Rs 247.9 from the previous close of Rs 219.8, a move of Rs 28.1 or 12.78%. The stock opened at Rs 259, reached a high of Rs 259, recorded a low of Rs 221.

Everest Organics Share Price rose Rs 28.1 today, moving from Rs 219.8 to Rs 247.9. The stock opened at Rs 259, touched Rs 259 and slipped to Rs 221 at the low before trading at Rs 247.9. This is a sharp price rise for Everest Organics Share Price Today and keeps Everest Organics Share Price in the list of Stocks Rising Today and Market Movers in Indian Stock Market watchlists.

For readers following Everest Organics Share Price Live, the key facts are straightforward: the move is large in percentage terms, the current price remains above the previous close, and the day’s range has been wide enough to keep price action central. According to latest Univest data, Everest Organics Share Price has not moved on a verified company-specific catalyst. That makes the trading pattern itself the main point to track as the market updates continue. From here, the next layer of analysis is the company’s valuation and balance-sheet context, which helps explain why Everest Organics Share Price is drawing attention today.

Everest Organics Ltd. (EVERESTO) Fundamental Analysis

Metric Value
Market Capitalisation Rs 219.22 crore
P/E Ratio 41.72x
P/B Ratio 2.72x
ROE -2.25%
ROCE 1.76%
EPS Rs 5.27
Book Value Per Share Rs 80.8
Dividend Yield 0%

Everest Organics Ltd. (EVERESTO) fundamental metrics show P/E 41.72x, P/B 2.72x, ROE -2.25%, ROCE 1.76%. Read together, these ratios describe the company’s position rather than a recommendation.

Everest Organics Ltd. has a market capitalisation of Rs 219.22 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.72x, P/B at 2.72x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -2.25% and ROCE of 1.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.27, book value per share of Rs 80.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.94x, median ROE of 11.53%, median ROCE of 13.24%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 41.72x
Benchmark Median P/E 31.94x
Benchmark Average P/E 48.28x
Benchmark P/E Range 3.58x to 685.2x
Company P/B Ratio 2.72x
Benchmark Median P/B 2.88x
Company ROE -2.25%
Benchmark Median ROE 11.53%
Company ROCE 1.76%
Benchmark Median ROCE 13.24%
Company Market Capitalisation Rs 219.22 crore
Benchmark Median Market Cap Rs 732.17 crore

Everest Organics Ltd. (EVERESTO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Everest Organics Ltd. (EVERESTO) has a P/E ratio of 41.72x, which is above the benchmark median of 31.94x, a difference of +30.62%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Everest Organics Ltd. (EVERESTO) has a ROE of -2.25%, which is below the benchmark median of 11.53%, a difference of -119.51%. Everest Organics Ltd. (EVERESTO) has a ROCE of 1.76%, which is below the benchmark median of 13.24%, a difference of -86.71%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,34,279.63 35.9 5.02 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,46,737.12 84.35 13.97 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,81,129.27 83.05 20.18 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,14,239.13 25.31 4.24 19.69 21.39
Cipla Ltd. CIPLA 1,08,808.05 32.28 3.1 11.83 16

Everest Organics Ltd. (EVERESTO) has a P/E ratio of 41.72x compared with the displayed peer median of 35.9x. Peer multiples give relative context only, not a buy or sell view. Its ROE of -2.25% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Everest Organics Ltd. (EVERESTO) has a market capitalisation of Rs 219.22 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Everest Organics

  • Everest Organics Share Price is up 12.78% today, making the stock stand out in the current Stock Market Today move list.
  • The price action is clear, but no company-specific catalyst is established, so Everest Organics Share Price remains a verified price-rise story first.
  • Everest Organics Share Price Today also needs to be read with P/E 41.72, P/B 2.72 and EPS 5.27 in mind.
  • The company’s ROE of -2.25% and ROCE of 1.76% keep Everest Organics Share Price under fundamental watch within Healthcare.
  • Everest Organics Share Price is far smaller than the key sector peers, which makes the market cap comparison important.

About Everest Organics

Everest Organics Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Everest Organics Share Price is linked to a business profile that belongs to the Indian pharmaceutical value chain, and the company’s market position is best understood through its valuation, capitalisation and operating return metrics. The latest Univest figures place Everest Organics Share Price at Rs 247.9, while the company’s book value is Rs 80.8 and EPS is 5.27. Those numbers help investors read the business beyond a single price move.

Everest Organics Share Price also reflects a company that is evaluated alongside peers with far larger market capitalisations and stronger returns on equity and capital employed. For readers tracking Everest Organics Stock News and Everest Organics Latest News, the business context is therefore a mix of sector participation, valuation measurement and performance comparison rather than a pure momentum story. In Univest analysis, that combination is often what keeps Everest Organics Share Price on watchlists.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Everest Organics Share Price rising today?

Ans. Everest Organics Share Price is rising today because it has gained 12.78% to Rs 247.9. According to Univest data, the price event is confirmed, but no company-specific catalyst is established for the move.

What is Everest Organics Share Price today?

Ans. Everest Organics Share Price is Rs 247.9 at the time of this update. It is higher than the previous close of Rs 219.8, keeping Everest Organics Share Price Today in active focus.

How much did Everest Organics Share Price rise today?

Ans. Everest Organics Share Price rose Rs 28.1, which equals 12.78%. The move pushed the stock from Rs 219.8 to Rs 247.9 and made it one of the notable risers in Healthcare.

What does Everest Organics Share Price valuation show?

Ans. Everest Organics Share Price carries a P/E of 41.72 and a P/B of 2.72. EPS is 5.27 and book value is 80.8, so valuation needs to be read with earnings quality in mind.

How does Everest Organics compare with Healthcare peers?

Ans. Everest Organics Share Price is much smaller than peers such as Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd. and Cipla Ltd. Its ROE and ROCE are also weaker than the listed peer group.

What is Everest Organics market capitalisation?

Ans. Everest Organics has a market capitalisation of Rs 219.22 crore. That places Everest Organics Share Price far below the market-cap levels of the larger Healthcare peers listed in the comparison set.

What are the key fundamentals for Everest Organics Share Price?

Ans. Key fundamentals for Everest Organics Share Price include P/E of 41.72, P/B of 2.72, EPS of 5.27, book value of 80.8, ROE of -2.25% and ROCE of 1.76. Dividend yield is 0.

Should investors track Everest Organics Share Price on Univest?

Ans. Yes, investors tracking Everest Organics Share Price can use Univest to follow live price updates, valuation ratios, market cap and sector context. It helps keep Everest Organics Share Price Today in a clear research frame.

Track Everest Organics Share Price on Univest

Use Everest Organics Ltd. (EVERESTO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Everest Organics Share Price on Univest for live price updates, market cap, valuation ratios, 52-week levels and company insights in one place. Everest Organics Share Price Today can be monitored alongside sector context, peer data and fundamental analysis, helping readers follow every new move in a structured way.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply